
Cymevene 500mg Injection is an antiviral medicine used to treat viral infections caused by cytomegalovirus (CMV) in immunocompromised people who have undergone an organ or bone marrow transplantation. It also reduces the risk of blindness in a serious eye infection caused by CMV, known as CMV retinitis.
Injection
500 mg
1.0 Injection in 1 vial
Store below 30°C
BSP Pharmaceuticals S.p.A.
Paviour Pharmaceuticals Avt. Ltd.,
Meeting Global Pharmaceutical Standards for Trusted International Trade
Procured through authorised distributors and companies, ensuring reliable quality and supply chain traceability.
Active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.
Pre-dispatch inspection, tamper-evident packing, and documentation verification for every shipment.
Treatment of Cytomegalovirus Infection
At ExSell Laboratories Pvt. Ltd., we aim to provide information that is accurate and reliable. All content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While every effort is made to maintain accuracy, the information provided may contain errors or omissions, or may not reflect the latest developments. Please consult a qualified healthcare professional regarding any medical concerns.
All product names, brand names, trademarks, and registered trademarks displayed on this website are the property of their respective owners. ExSell Laboratories Pvt. Ltd. and this website are not affiliated with, endorsed by, or authorized by any such trademark owners, unless expressly stated. References to product names or trademarks are made solely for descriptive and informational purposes, and no commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Nothing herein constitutes promotion, advertising, or an offer for sale of any medicinal product.
All trademarks and brand names on this website are used strictly in accordance with the Trade Marks Act, 1999 — specifically Sections 30 and 30(1) governing fair use — and any related parallel trade is conducted consistent with the trademark exhaustion and fair-use provisions of the Act, as well as India's obligations as a WTO member under the TRIPS Agreement.
"Trademark ownership is duly attributed under the 'Marketing/TM Owner' section in accordance with applicable statutory requirements."
Essential information on active composition, quality standards, cold-chain storage, and international export.
Cymevene 500mg Injection is a certified pharmaceutical product from our Global export catalogue formulated as an Injection (500 mg). It contains the active pharmaceutical ingredient Ganciclovir (500mg), manufactured by BSP Pharmaceuticals S.p.A..
Cymevene 500mg Injection is manufactured by BSP Pharmaceuticals S.p.A. – Meeting Global Pharmaceutical Standards for Trusted International Trade. ExSell Laboratories delivers authenticated batches sourced through verified, compliant supply channels, backed by complete regulatory documentation.
Cymevene 500mg Injection must be stored according to manufacturer instructions: Store below 30°C. ExSell Laboratories maintains active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.
Yes, ExSell Laboratories is a licensed global pharmaceutical exporter supplying hospitals, pharmacies, government procurement agencies, and distributors in 45+ countries. Contact our sales team for bulk quotation, MOQ, and international shipping options.
Verified equivalent brands and bioequivalent formulations containing Ganciclovir (500mg).

Ganciclovir 500mg

Ganciclovir (500mg)

Valganciclovir 450 mg

Valganciclovir (450mg)
Cymevene 500mg Injection
500 mg